Researchers suggest a possible cell-based therapy to stimulate lung development in fragile premature infants who suffer from a rare condition called Bronchopulmonary Dysplasia (BPD), which in the most severe cases can lead to lifelong breathing problems and even death. Scientists studied genetic signatures in donated human neonatal lungs by using single-cell RNA sequencing analysis and mouse models of BPD.